New insights in nutritional management and amino acid supplementation in urea cycle disorders

Molecular Genetics and Metabolism

Volumn 100, Issue SUPPL., 2010, Pages

  Scaglia, Fernando ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Branched chain amino acids; Sodium phenylbutyrate; Urea cycle disorders

Indexed keywords

4 PHENYLBUTYRIC ACID; AMINO ACID; BRANCHED CHAIN AMINO ACID; ESSENTIAL AMINO ACID; GLUTAMINE; GLUTAMINE DERIVATIVE; PHENYLACETIC ACID; PHENYLACETYLGLUTAMINE; STABLE ISOTOPE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; CITRULLINEMIA; CONJUGATION; DIET SUPPLEMENTATION; DIET THERAPY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; HUMAN; INBORN ERROR OF METABOLISM; NITROGEN URINE LEVEL; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN RESTRICTION; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; UREA CYCLE DISORDER;

ADOLESCENT; ADULT; AMINO ACIDS; CHILD; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; UREA CYCLE DISORDERS, INBORN;

EID: 77950313953     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2010.02.019     Document Type: Review

References (47)

1. Brusilow S.W. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr. Res. 29 2 (1991) 147-150
2. James M.O., Smith R.L., Williams R.T., and Reidenberg M. The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species. Proc. R. Soc. Lond. B Biol. Sci. 182 66 (1972) 25-35
3. Maestri N.E., McGowan K.D., and Brusilow S.W. Plasma glutamine concentration: a guide in the management of urea cycle disorders. J. Pediatr. 121 2 (1992) 259-261
4. Lee B., Yu H., Jahoor F., O'Brien W., Beaudet A.L., and Reeds P. In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle. Proc. Natl. Acad. Sci. U. S. A. 97 14 (2000) 8021-8026
5. Kasumov T., Brunengraber L.L., Comte B., Puchowicz M.A., Jobbins K., Thomas K., et al. New secondary metabolites of phenylbutyrate in humans and rats. Drug Metab. Dispos. 32 1 (2004) 10-19
6. Maestri N.E., Clissold D.B., and Brusilow S.W. Long-term survival of patients with argininosuccinate synthetase deficiency. J. Pediatr. 127 6 (1995) 929-935
7. Darmaun D., Welch S., Rini A., Sager B.K., Altomare A., and Haymond M.W. Phenylbutyrate-induced glutamine depletion in humans: effect on leucine metabolism. Am. J. Physiol. 274 5 Pt. 1 (1998) E801-E807
8. Scaglia F., Carter S., O'Brien W.E., and Lee B. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients. Mol. Genet. Metab. 81 Suppl. 1 (2004) S79-S85
9. Scaglia F., Lampher B., Marini J., and Lee B. Role of branched-chain amino acids in patients with urea cycle disorders. In: Bachmann C., Haberle J., and Leonard J. (Eds). International Symposium on Pathophysiology and Management of Hyperammonemia, Fulda (2007), SPS Verlagsgesellschaft, Germany 65-75
10. Le Bacquer O., Mauras N., Welch S., Haymond M., and Darmaun D. Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans. Clin. Nutr. 26 2 (2007) 231-238
11. Bergstrom J., Furst P., Noree L.O., and Vinnars E. Intracellular free amino acid concentration in human muscle tissue. J. Appl. Physiol. 36 6 (1974) 693-697
12. Lacey J.M., and Wilmore D.W. Is glutamine a conditionally essential amino acid?. Nutr. Rev. 48 8 (1990) 297-309
13. Hankard R.G., Haymond M.W., and Darmaun D. Effect of glutamine on leucine metabolism in humans. Am. J. Physiol. 271 4 Pt. 1 (1996) E748-E754
14. Wernerman J., Hammarqvist F., and Vinnars E. Alpha-ketoglutarate and postoperative muscle catabolism. Lancet 335 8691 (1990) 701-703
15. Humbert B., Nguyen P., Dumon H., Deschamps J.Y., and Darmaun D. Does enteral glutamine modulate whole-body leucine kinetics in hypercatabolic dogs in a fed state?. Metabolism 51 5 (2002) 628-635
16. Boza J.J., Turini M., Moennoz D., Montigon F., Vuichoud J., Gueissaz N., et al. Effect of glutamine supplementation of the diet on tissue protein synthesis rate of glucocorticoid-treated rats. Nutrition 17 1 (2001) 35-40
17. Le Bacquer O., Nazih H., Blottiere H., Meynial-Denis D., Laboisse C., and Darmaun D. Effects of glutamine deprivation on protein synthesis in a model of human enterocytes in culture. Am. J. Physiol. Gastrointest. Liver Physiol. 281 6 (2001) G1340-G1347
18. Le Bacquer O., Laboisse C., and Darmaun D. Glutamine preserves protein synthesis and paracellular permeability in Caco-2 cells submitted to "luminal fasting". Am. J. Physiol. Gastrointest. Liver Physiol. 285 1 (2003) G128-G136
19. Rabier D. Ammonia production and detoxification. In: Bachmann C., Haberle J., and Leonard J. (Eds). International Symposium on Pathophysiology and Management of Hyperammonemia, Fulda (2007), SPS Verlagsgesellschaft, Germany 11-24
20. Stehle P., Zander J., Mertes N., Albers S., Puchstein C., Lawin P., et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet 1 8632 (1989) 231-233
21. Morlion B.J., Stehle P., Wachtler P., Siedhoff H.P., Koller M., Konig W., et al. Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann. Surg. 227 2 (1998) 302-308
22. Hankard R.G., Haymond M.W., and Darmaun D. ESPEN research fellows symposia-presented at ESPEN 1995, Effect of enteral glutamine on glutamine and leucine metabolism in humans. Clin. Nutr. 15 2 (1996) 84-85
23. Hankard R.G., Hammond D., Haymond M.W., and Darmaun D. Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystrophy. Pediatr. Res. 43 2 (1998) 222-226
24. Tuchman M., Lee B., Lichter-Konecki U., Summar M.L., Yudkoff M., Cederbaum S.D., et al. Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol. Genet. Metab. 94 4 (2008) 397-402
25. Odessey R., Khairallah E.A., and Goldberg A.L. Origin and possible significance of alanine production by skeletal muscle. J. Biol. Chem. 249 23 (1974) 7623-7629
26. Hod G., Chaouat M., Haskel Y., Lernau O.Z., Nissan S., and Mayer M. Ammonia uptake by skeletal muscle in the hyperammonaemic rat. Eur. J. Clin. Invest. 12 6 (1982) 445-450
27. Limberg B., and Kommerell B. Why decreased serum branched-chain amino acids in cirrhosis. Gastroenterology 80 1 (1981) 211-212
28. Iwasaki Y., Sato H., Ohkubo A., Sanjo T., Futagawa S., Sugiura M., et al. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations. Gastroenterology 78 4 (1980) 677-683
29. Matsubara S., Ouchi K., Okabe K., Suzuki M., and Matsuno S. Clinical outcome of non-shunting operation for oesophageal varices in patients with liver cirrhosis. J. Gastroenterol. Hepatol. 4 Suppl. 1 (1989) 235-238
30. Strombeck D.R., Rogers Q.R., and Stern J.S. Effects of ammonia infusion on plasma glucagon, insulin, and amino acids in intact, pancreatectomized, and adrenalectomized dogs. Am. J. Vet. Res. 42 5 (1981) 810-818
31. Leweling H., Breitkreutz R., Behne F., Staedt U., Striebel J.P., and Holm E. Hyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasma. J. Hepatol. 25 5 (1996) 756-762
32. Gore S.D., Samid D., and Weng L.J. Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells. Clin. Cancer Res. 3 10 (1997) 1755-1762
33. Waxman S. Differentiation therapy in acute myelogenous leukemia (non-APL). Leukemia 14 3 (2000) 491-496
34. Andratschke N., Grosu A.L., Molls M., and Nieder C. Perspectives in the treatment of malignant gliomas in adults. Anticancer Res. 21 5 (2001) 3541-3550
35. Kern R.M., Yang Z., Kim P.S., Grody W.W., Iyer R.K., and Cederbaum S.D. Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines. Mol. Genet. Metab. 90 1 (2007) 37-41
36. Yeaman S.J. The 2-oxo acid dehydrogenase complexes: recent advances. Biochem. J. 257 3 (1989) 625-632
37. Peng T., Golub T.R., and Sabatini D.M. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell. Biol. 22 15 (2002) 5575-5584
38. Buse M.G., and Reid S.S. Leucine. A possible regulator of protein turnover in muscle. J. Clin. Invest. 56 5 (1975) 1250-1261
39. Anthony J.C., Anthony T.G., Kimball S.R., Vary T.C., and Jefferson L.S. Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation. J. Nutr. 130 2 (2000) 139-145
40. Anthony J.C., Yoshizawa F., Anthony T.G., Vary T.C., Jefferson L.S., and Kimball S.R. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J. Nutr. 130 10 (2000) 2413-2419
41. Wullschleger S., Loewith R., and Hall M.N. Signaling in growth and metabolism. Cell 124 3 (2006) 471-484
42. Meijer A.J. Amino acid regulation of autophagosome formation. Methods Mol. Biol. 445 (2008) 89-109
43. Greiwe J.S., Kwon G., McDaniel M.L., and Semenkovich C.F. Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 281 3 (2001) E466-E471
44. Hay N., and Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 18 16 (2004) 1926-1945
45. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110 2 (2002) 163-175
46. Avruch J., Long X., Ortiz-Vega S., Rapley J., Papageorgiou A., and Dai N. Amino acid regulation of TOR complex 1. Am. J. Physiol. Endocrinol. Metab. 296 4 (2009) E592-E602
47. Bachmann C. Hyperammonemia: Review of current treatment strategies. In: Bachmann C., Haberle J., and Leonard J. (Eds). International Symposium on Pathophysiology and Management of Hyperammonemia, Fulda (2007), SPS Verlagsgesellschaft, Germany 157-173